Neurocrine Biosciences
NBIX
#1611
Rank
โ‚น874.21 B
Marketcap
โ‚น8,768
Share price
-5.01%
Change (1 day)
-23.63%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

EPS for Neurocrine Biosciences (NBIX)

EPS in 2023 (TTM): โ‚น162.41

According to Neurocrine Biosciences 's latest financial reports the company's current EPS (TTM) is โ‚น167.04. In 2022 the company made an earnings per share (EPS) of โ‚น137.22 an increase over its 2021 EPS that were of โ‚น80.97.

EPS history for Neurocrine Biosciences from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น162.4118.36%
2022โ‚น137.2269.47%
2021โ‚น80.97-78.21%
2020โ‚น371.59990%
2019โ‚น34.0981.82%
2018โ‚น18.75-113.5%
2017-โ‚น138.920.62%
2016-โ‚น138.0757.28%
2015-โ‚น87.7825.61%
2014-โ‚น69.8918.84%
2013-โ‚น58.81-1085.71%
2012โ‚น5.97-89.71%
2011โ‚น57.95-500%
2010-โ‚น14.49-86.92%
2009-โ‚น110.80-43.48%
2008-โ‚น196.02-57.8%
2007-โ‚น464.4992.58%
2006-โ‚น241.19371.67%
2005-โ‚น51.14-52.76%
2004-โ‚น108.2436.56%
2003-โ‚น79.26-70%
2002-โ‚น264.20118.31%
2001-โ‚น121.028.4%
2000-โ‚น111.6548.86%
1999-โ‚น75.00-20%
1998-โ‚น93.75-479.31%
1997โ‚น24.72

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น178.12 6.63%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น46.87-71.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
-โ‚น252.27-251.02%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น462.72 177.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น313.69 87.79%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น158.52-5.10%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น40.06-123.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น258.24-254.59%๐Ÿ‡บ๐Ÿ‡ธ USA